Health

Three scientists are honored for developing a class of blockbuster weight-loss drugs. Is a Nobel prize on the way?

In the U.S. in the early 1960s the distributor of a thalidomide drug was impatient to get it on the market. But FDA medical examiner Frances Oldham Kelsey wanted more information to prove its safety

You have around 35 trillion red blood cells moving around your body at all times. Typically they are rounded and flexible. What happens when they aren’t?

Days spent in a desk chair can lead to heart disease or cancer. Getting up often and exercising more vigorously can stave off the ill effects

Illuminating the experience of people living with sickle cell could improve patients’ lives and enhance all of medicine

Life expectancy for people with sickle cell in the U.S. has increased to about 50 years, but some people with the disease still face stigma and other barriers in health care

Increased funding and new public health policies for sickle cell research are needed to ease the burden on low-income nations and improve patient care

The FDA recently approved three sickle cell drugs, and dozens more are in development

These sickle cell researchers and advocates are driving change from labs to global stages, transforming lives in the process.

Improving sickle cell care by expanding treatment options, advancing new therapies and amplifying the voices of people with the disease

Sickle cell disease causes severe pain that’s hard to treat, but researchers are finding new ways to offer relief

The predictive value of childhood screenings for autism and other conditions depends on how common the condition is, a limit that parents need to understand